The Kidney Cancer Research Consortium is funded via a Department of Defense grant.
CLINICAL TRIALS

Cardiovascular Surveillance of Immune Checkpoint Inhibitor-Based Combination Therapy in Patients With Advanced Renal Cell Cancer: Data From the Phase III JAVELIN Renal 101 Trial

by | Mar 3, 2022 | Uncategorized | 0 comments

https://pubmed.ncbi.nlm.nih.gov/35239416/

Submit a Comment

Your email address will not be published. Required fields are marked *